These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
119 related items for PubMed ID: 6614939
21. [Treatment of hematological malignancies with recombinant leukocyte A interferon (rIFN-alpha A)]. Ohno R, Kodera Y, Ogura M, Murase T, Emi N, Okumura M, Morishita Y, Nagura E, Minami S, Morishima Y. Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2531-6. PubMed ID: 6594973 [Abstract] [Full Text] [Related]
22. [Clinical study on the effect of human lymphoblastoid interferon in B-cell malignancies]. Takeyama H, Yano K, Kataoka T, Watanabe E, Kobayashi M, Ohno R. Rinsho Ketsueki; 1984 Dec; 25(12):1921-7. PubMed ID: 6442741 [No Abstract] [Full Text] [Related]
23. [Plasma concentration of alpha-interferon following continuous subcutaneous infusion]. Tari K, Tsujii T, Yonese J. Gan To Kagaku Ryoho; 1988 Jul; 15(7):2159-61. PubMed ID: 3395139 [Abstract] [Full Text] [Related]
24. [Phase I study of human lymphoblastoid alpha-interferon on malignant tumor]. Furue H. Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):977-83. PubMed ID: 3963861 [Abstract] [Full Text] [Related]
25. [The effect of human lymphoblastoid interferon (HLBI) on the growth of 2 human malignant melanoma xenografts in nude mice]. Hashizume S. Gan To Kagaku Ryoho; 1984 Jun; 11(6):1296-302. PubMed ID: 6732256 [Abstract] [Full Text] [Related]
26. [Treatment of condyloma acuminata using human lymphoblastoid interferon]. Kinukawa T, Hattori R, Furukawa T, Ohshima S, Matsuura O, Takeuchi N, Tanaka K, Hashimoto J, Ono Y, Watanabe J. Hinyokika Kiyo; 1990 Nov; 36(11):1295-300. PubMed ID: 2288309 [Abstract] [Full Text] [Related]
27. Phase I study of Wellferon (human lymphoblastoid alpha-interferon) as cancer therapy: clinical results. Sarna G, Figlin R, McCarthy S. J Biol Response Mod; 1983 Nov; 2(2):187-95. PubMed ID: 6644335 [Abstract] [Full Text] [Related]
28. [Clinical study on the effect of natural alpha-interferon (HLBI) in the treatment of adult T-cell leukemia]. Ichimaru M, Kamihira S, Moriuchi Y, Kuraishi Y, Usui N, Toki H, Okabe K, Niho Y, Shibuya T, Umei T. Gan To Kagaku Ryoho; 1988 Oct; 15(10):2975-81. PubMed ID: 3052302 [Abstract] [Full Text] [Related]
29. Intratumoural and intraventricular human lymphoblastoid alpha interferon (HLBI) for treatment of glioblastoma multiforme. Martínez R, Vaquero J, Ramiro J, García Salazar F, De Oya S. Acta Neurochir (Wien); 1989 Oct; 100(1-2):46-9. PubMed ID: 2554692 [Abstract] [Full Text] [Related]
30. Phase II trial of lymphoblastoid interferon in metastatic colon carcinoma. Chaplinski T, Laszlo J, Moore J, Silverman P. Cancer Treat Rep; 1983 Nov; 67(11):1009-12. PubMed ID: 6640552 [Abstract] [Full Text] [Related]
31. Treatment of multiple myeloma with recombinant interferon alfa-2a. Ohno R, Kimura K. Cancer; 1986 Apr 15; 57(8 Suppl):1685-8. PubMed ID: 3948139 [Abstract] [Full Text] [Related]
32. [Clinical and immunological studies of human fibroblast interferon and human lymphoblastoid interferon in malignant diseases]. Ezaki K. Gan No Rinsho; 1983 May 15; 29(6):598-602. PubMed ID: 6308306 [No Abstract] [Full Text] [Related]
33. [Clinical study of renal cell carcinoma]. Yamada Y, Fukatsu H, Honda N, Miyagawa Y, Segawa A. Hinyokika Kiyo; 1993 Dec 15; 39(12):1197-203. PubMed ID: 7506869 [Abstract] [Full Text] [Related]
34. [Clinical efficacy of interferon-beta (MR-21) in hematological malignancies]. Imamura Y. Nihon Gan Chiryo Gakkai Shi; 1987 Jun 20; 22(5):934-41. PubMed ID: 3694002 [No Abstract] [Full Text] [Related]
35. [Clinical study of recombinant interferon alpha-2 (Sch 30500) in advanced gynecological cancers]. Kasamatsu T, Ohmi K, Takeuchi S, Takamizawa H, Matsuzawa M, Kawana T, Ueda K, Kubo H, Tsumuji Y, Kawashima Y. Gan To Kagaku Ryoho; 1985 Aug 20; 12(8):1656-60. PubMed ID: 3896157 [Abstract] [Full Text] [Related]
36. [Current status and problems of cancer treatment with interferon]. Ichikawa H. Gan No Rinsho; 1983 May 20; 29(6):616-9. PubMed ID: 6876430 [Abstract] [Full Text] [Related]
37. Phase II trial of alpha (human leukocyte) interferon administered daily in adenocarcinoma of the colon/rectum. Figlin RA, Callaghan M, Sarna G. Cancer Treat Rep; 1983 May 20; 67(5):493-4. PubMed ID: 6850664 [Abstract] [Full Text] [Related]
38. The antitumor effects of human lymphoblastoid interferon on human renal cell carcinoma in athymic nude mice. Yamaoka T, Takada H, Yanagi Y, Kataoka T, Sakurai Y. Cancer Chemother Pharmacol; 1985 May 20; 14(3):184-7. PubMed ID: 3995680 [Abstract] [Full Text] [Related]
39. Human lymphoblastoid interferon therapy for advanced renal cell carcinoma. Marumo K, Murai M, Hayakawa M, Tazaki H. Urology; 1984 Dec 20; 24(6):567-71. PubMed ID: 6506397 [Abstract] [Full Text] [Related]
40. [Successful management for advanced renal cell carcinoma under combination therapy with human lymphoblastoid interferon-alpha and UFT (mixture of tegafur and uracil): a case report]. Kanno H, Kitami K, Senga Y, Takahashi T, Nagashima Y. Hinyokika Kiyo; 1993 Aug 20; 39(8):725-9. PubMed ID: 8379474 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]